介绍
Yein Han is a partner with a background as a pharmacist and focuses on pharmaceutical and biotech patent litigation as well as advisory services and litigation in healthcare.
Based on her experience in representing global and domestic pharmaceutical companies, she is recognized for her ability to employ both offensive and defensive strategies in pharmaceutical and biotech patent disputes. Furthermore, she provides advisory and litigation services relating to pharmaceuticals, medical devices, cosmetics, household chemical products, etc. based on specialized knowledge of pharmacy and an understanding of the industry.
履历
2024-至今
Bae, Kim & Lee LLC
2016-2024
Lee & Ko
2013-2015
FirstLaw P.C.
2012
Y.P. Lee, Mock & Partners
其他经历
2022-至今
Adjunct Professor, Sungkyunkwan University Law School
2022-2024
Member of the Committee of Experts on In Vitro Diagnostic Medical Devices
2015
Completed Ph.D. coursework in Intellectual Property Law, Sungkyunkwan University Law School
主要业务案例
Represented a global pharmaceutical company in a case involving invalidation of a patent for an anticancer medication/confirmation of the scope of rights
Represented a global pharmaceutical company in a case involving invalidation of a patent for an asthma medication
Represented a global pharmaceutical company in a case involving invalidation of a patent for an antibiotic/confirmation of the scope of rights
Represented a global pharmaceutical company in a case involving invalidation of a patent for a heart failure medication/confirmation of the scope of rights
Represented a global pharmaceutical company in a case involving invalidation of a patent for a diabetes medication/confirmation of the scope of rights
Represented a Korean bio company in a case involving invalidation/infringement of a patent relating to a medication for nocturnal hemoglobinuria
Represented a Korean bio company in a case involving invalidation/infringement of a patent relating to a medication for rheumatic disease
Represented a Korean bio company in a case involving invalidation/infringement of a patent relating to a medication for breast cancer
Represented a Korean bio company in a case involving invalidation/infringement of a patent relating to an anticancer medication
Represented a Korean bio company in a case involving invalidation of a patent relating to pharmaceutical formulations
Represented a Korean pharmaceutical company in a case involving infringement of a patent for an osteoarthritis medication
Represented a Korean pharmaceutical company in a case involving invalidation of a patent for an antibiotic
Represented a Korean pharmaceutical company in a case involving invalidation/infringement of a patent for an antiulcer medication
Represented a domestic pharmaceutical company in an appeal against a decision to reject a patent application for an antiviral medication
Engaged in a case for invalidation of a patent for natural health functional food
Engaged in the Korea Trade Commission's investigation of unfair trade practices with respect to infringement of a parent for chemical compositions
Engaged in the Korea Trade Commission's investigation of unfair trade practices with respect to infringement of an LCD patent
Engaged in a case involving invalidation of an LCD patent
Engaged in a case involving invalidation/infringement of a patent relating to chemical compositions for an oxidation inhibitor
Engaged in a case involving infringement of trade secrets between cosmetics companies
Engaged in a case involving invalidation/infringement of a trademark between cosmetics companies
Engaged in a case involving prohibition on unfair competition with respect to imitation of a global company's product
Engaged in a case involving invalidation of a food patent
Engaged in a civil and criminal case involving infringement of trademark rights for kitchenware
Performed various advisory services with respect to potential infringement and invalidation of patents for pharmaceutical products
Provided advice on drug patent license agreements
Performed various advisory services with respect to the drug approval-patent linkage system
Provided advice on the scope of compensation for in-service inventions
Engaged in a criminal case involving humidifier disinfectants and a case involving violation of the Act on Fair Labeling and Advertising, and responded to a hearing before the National Assembly
Engaged in an administrative litigation case with respect to the re-evaluation of drug reimbursement adequacy
Engaged in an administrative litigation case with respect to drug price reduction
Engaged in a civil case involving a defect in a cosmetics company's product
Engaged in a criminal case involving violation of the Medical Devices Act
Engaged in a criminal case involving violation of the Financial Investment Services and Capital Markets Act by a medical device company
Engaged in a lawsuit for unjust enrichment relating to the detection of impurities in pharmaceuticals filed against the National Health Insurance Service
Engaged in a lawsuit involving insurance relating to the off-label prescription of pharmaceuticals
Engaged in a civil and criminal case relating to forgery of documents by a former officers of a pesticide company
Engage in a lawsuit relating to the scope of duties of doctors of oriental medicine
Engage in a lawsuit for revocation of pharmaceutical product approval
Engage in a lawsuit relating to the national lot release of botox products
Responded to, and engaged in a lawsuit involving the suspension of manufacture and sale of pharmaceutical products, and business, etc.
Provided advice on clinical performance tests under the Act on In Vitro Diagnostic Medical Devices
Provided advice on application for new/innovative medical technology
Provided advice on application for confirmation of medical care benefit items and non-benefit items
Provided advice on the procedures for approval for clinical trial plans
Provided advice on the designation of drugs under the drug shortage prevention program
Engaged in a product for expansion of pharmaceutical reimbursement standards
Provided advice on price reduction of drugs based on actual transaction prices
Provided advice on clinical re-evaluation of pharmaceutical products
Provided advice on joint development agreements, exclusive distribution agreements, contract manufacturing agreements, and confidentiality agreements, etc. between pharmaceutical companies
Provided advice on the safety of household environment products
Provided advice on approvals for non-prescription medical products upon entry into the Korea market by foreign companies
Provided advice on approvals under the Medical Devices Act and GMP
Provided advice on pharmaceutical GMP, product approval, labeling and advertising, and clinical trials
Advised a foreign pharmaceutical company on the approval for a plan for clinical trials in Korea
Advised a global pharmaceutical company on the designation of orphan drugs
Provided advice on response relating to violation of the LMO Act
Provided advice on the National Immunization Program (NIP)
Advised a Korean pharmaceutical company on rebates
学历
2020
UCLA School of Law (LL.M.)
2012
Sungkyunkwan University Law School (J.D.)
2008
Sungkyunkwan University (B.S.)
主要社会活动
著作
Patent Right Infringement of a Second Medical Use Invention: Focusing on the Pregabalin Decision (Seoul Central District Court 2016 Gahab 517156 Decision), Vol. 32, No. 4, pp. 279 - 337 (Co-author, Sungkyunkwan Law, 2020)
Infringement of Patent Rights for the Use Invention of Pfizer's Lyrica: Is a Second Use Invention an Article Invention or a Process Invention? (Co-author, contribution to Patent and Trademark, 2017)
Lexology In-depth: Pharmaceutical Intellectual Property and Competition: South Korea (2022-2024)
活动
Panelist for the Bench & Bar Conference 'Determination of Inventiveness of Medical Use Inventions, Mecial Use Inventions and Insufficient Description' (Patent Court/Korean Intellectual Property Lawyers Association (KIPLA), 2024)
Lecture on 'Verification of Causation in Medical Lawsuits,' special training on the Mecial Service Act (Korean Bar Association, 2024)
Lecture on the 'Impact and Key Issues of the Introduction of the Pharmaceutical Cost Recovery and Refund System relating to Suspension of Execution' (NewsTheVoice, 2023)
Lectured in the advanced course of the training on the drug approval-patent linkage system organized (Ministry of Food and Drug Safety, 2022-2023)
Panelist for the '2022 Pharmaceutical Intellectual Property Policy Forum' (Ministry of Food and Drug Safety, 2022)
Panelist for the 'Practices and Legal Issues in Calculation of Damages for Intellectual Property Rights' (Korea Intellectual Property Office/Korea Intellectual Property Society, 2021)
奖项
Legal Times - IP Leading Lawyer (2024)
资格
2020
New York
2014
Patent Attorney (Korea)
2012
Korea
2008
Pharmacist (Korea)
